Resumption of Enteral Feeding After Bowel Anastomosis

NCT ID: NCT06906289

Last Updated: 2025-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

204 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Resumption of oral feeding after small intestine surgery is a matter of controversy .Some surgeons advocate early resumption while others don't.early feeding is initiated as soon as the patient recovers from effects of anaesthesia, while late resumption is started after 24-48 hours after surgery.Recent studies and guidelines suggest early feeding. The aim of this study is to compare the early and late resumption of oral feeding.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Enhanced Recovery After Surgery Hospital Stay, Length of Stay in Hospital From Time of Surgery Till Discharge Defecation Vomiting, Postoperative Anastomotic Leak Flatus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early group

Early group includes patients in whom enteral feeding is resumed within 24 hours once fully conscious from effects of anesthesia

Group Type EXPERIMENTAL

resumption of enteral feeding within 24 hours of surgery

Intervention Type OTHER

Patients will be subjected to resumption of enteral feeding within 24 hours of surgery

resumption of enteral feeding after 24-48 hours

Intervention Type OTHER

Patients will be subjected to late resumption of enteral feeding after 24 to 48 hours of surgery

Late group

Late group includes patients in whom enteral feeding is started 24-48 hours after recovery from anesthesia

Group Type EXPERIMENTAL

resumption of enteral feeding within 24 hours of surgery

Intervention Type OTHER

Patients will be subjected to resumption of enteral feeding within 24 hours of surgery

resumption of enteral feeding after 24-48 hours

Intervention Type OTHER

Patients will be subjected to late resumption of enteral feeding after 24 to 48 hours of surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

resumption of enteral feeding within 24 hours of surgery

Patients will be subjected to resumption of enteral feeding within 24 hours of surgery

Intervention Type OTHER

resumption of enteral feeding after 24-48 hours

Patients will be subjected to late resumption of enteral feeding after 24 to 48 hours of surgery

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients undergoing small bowel anastomosis for any indication in elective setting
* Patients of age between 15 to 65 years.
* All genders

Exclusion Criteria

* Patient using glucocorticoids or other immunosuppressive drugs
* non conseting individuals
* Patient having history of gastrectomy
Minimum Eligible Age

15 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Khyber Teaching Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Saeed Sarwar

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Khyber Teaching Hospital

Peshawar, KPK, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Saeed Sarwar, MBBS

Role: CONTACT

+92342 0973863

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Saeed Sarwar, MBBS

Role: primary

+923420973863

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

806/DME/KMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Postoperative Oral Intake Trial
NCT00134407 COMPLETED PHASE1